BLOOD AND CANCER THERAPEUTICS A MEDICAL CORPORATION
NPI: 1679184535
· BAKERSFIELD, CA 93306
· 207RH0003X
$4.19M
Total Medicaid Paid
Monthly Spending Trend
Yearly Breakdown
| Year | Claims | Total Paid |
|---|
| 2021 |
1,142 |
$51K |
| 2022 |
4,690 |
$146K |
| 2023 |
14,176 |
$1.13M |
| 2024 |
21,763 |
$2.86M |
Billing Codes
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| J9271 |
Inj pembrolizumab |
246 |
183 |
$1.41M |
| J9299 |
Injection, nivolumab |
167 |
94 |
$739K |
| Q5107 |
Inj mvasi 10 mg |
491 |
235 |
$472K |
| 96413 |
|
4,582 |
2,209 |
$383K |
| 96365 |
|
3,806 |
1,576 |
$212K |
| Q5126 |
Inj alymsys 10 mg |
134 |
69 |
$203K |
| J9312 |
Inj., rituximab, 10 mg |
62 |
24 |
$193K |
| 99215 |
Prolong outpt/office vis |
929 |
876 |
$95K |
| 96361 |
|
8,523 |
3,221 |
$91K |
| Q5119 |
Inj ruxience, 10 mg |
91 |
50 |
$72K |
| 96367 |
|
2,415 |
1,016 |
$57K |
| 99214 |
|
1,003 |
967 |
$52K |
| 96415 |
|
1,401 |
693 |
$47K |
| 96417 |
|
1,683 |
911 |
$44K |
| 99205 |
Prolong outpt/office vis |
271 |
270 |
$35K |
| 99213 |
|
615 |
567 |
$30K |
| 96368 |
|
1,924 |
783 |
$24K |
| J1750 |
Inj iron dextran |
299 |
143 |
$7K |
| J7050 |
Normal saline solution infus |
6,782 |
2,882 |
$6K |
| 99203 |
|
53 |
52 |
$5K |
| 96372 |
|
461 |
251 |
$5K |
| J7040 |
Normal saline solution infus |
3,613 |
1,540 |
$4K |
| 99204 |
|
52 |
52 |
$3K |
| J2405 |
Ondansetron hcl injection |
911 |
351 |
$1K |
| J1100 |
Dexamethasone sodium phos |
868 |
343 |
$632.21 |
| J1200 |
Diphenhydramine hcl injectio |
228 |
121 |
$152.78 |
| J2930 |
Methylprednisolone injection |
24 |
15 |
$122.37 |
| J3420 |
Vitamin b12 injection |
137 |
92 |
$74.83 |